Caprock Group, Inc. Gilead Sciences, Inc. Transaction History

Caprock Group, Inc.

$2.43 Billion
Q2 2024

A detailed history of Caprock Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 40,177 shares of GILD stock, worth $3.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

40,177

Previous 27,891 44.05%

Holding current value

$3.4 Million

Previous $2.04 Million 34.9%

% of portfolio

0.11%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $775,860 - $895,403	12,286 Added 44.05%	40,177 $2.76 Million
Q1 2024 Apr 29, 2024	BUY	$71.58 - $87.29 $49,175 - $59,968	687 Added 2.53%	27,891 $2.04 Million
Q4 2023 Jan 18, 2024	BUY	$73.27 - $83.09 $2,930 - $3,323	40 Added 0.15%	27,204 $2.2 Million
Q3 2023 Oct 18, 2023	SELL	$73.94 - $80.67 $131,761 - $143,753	-1,782 Reduced 6.16%	27,164 $2.04 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $47,354 - $54,014	623 Added 2.2%	28,946 $2.23 Million
Q1 2023 Apr 26, 2023	BUY	$77.31 - $88.08 $143,410 - $163,388	1,855 Added 7.01%	28,323 $2.35 Million
Q4 2022 Jan 23, 2023	BUY	$62.32 - $89.47 $4,175 - $5,994	67 Added 0.25%	26,468 $0
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $175,226 - $200,153	2,943 Added 12.55%	26,401 $1.63 Million
Q2 2022 Jul 26, 2022	BUY	$57.72 - $65.01 $178,181 - $200,685	3,087 Added 15.15%	23,458 $1.45 Million
Q1 2022 Apr 12, 2022	BUY	$57.92 - $72.58 $43,613 - $54,652	753 Added 3.84%	20,371 $1.21 Million
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $76,169 - $86,453	-1,174 Reduced 5.65%	19,618 $1.43 Million
Q3 2021 Oct 07, 2021	SELL	$67.69 - $73.03 $127,934 - $138,026	-1,890 Reduced 8.33%	20,792 $1.45 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $655,581 - $716,316	10,329 Added 83.62%	22,682 $1.56 Million
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $243,600 - $277,947	4,060 Added 48.96%	12,353 $798,000
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $320,978 - $365,740	-5,666 Reduced 40.59%	8,293 $483,000
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $799,289 - $1 Million	-12,871 Reduced 47.97%	13,959 $882,000
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $293,772 - $341,124	4,061 Added 17.84%	26,830 $2.06 Million
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $945,900 - $1.21 Million	15,103 Added 197.01%	22,769 $1.7 Million
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $58,970 - $64,865	-957 Reduced 11.1%	7,666 $498,000
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $44,632 - $49,266	714 Added 9.03%	8,623 $547,000
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $151,705 - $170,119	2,452 Added 44.93%	7,909 $534,000
Q1 2019 Apr 12, 2019	BUY	$62.53 - $70.05 $42,395 - $47,493	678 Added 14.19%	5,457 $355,000
Q4 2018 Jan 29, 2019	BUY	$60.54 - $79.0 $14,953 - $19,513	247 Added 5.45%	4,779 $299,000
Q3 2018 Oct 17, 2018	SELL	$71.28 - $78.92 $31,006 - $34,330	-435 Reduced 8.76%	4,532 $350,000
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $58,327 - $68,036	899 Added 22.1%	4,967 $352,000
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $874 - $1,065	12 Added 0.3%	4,068 $307,000
Q4 2017 Jan 17, 2018	SELL	$71.15 - $83.52 $69,869 - $82,016	-982 Reduced 19.49%	4,056 $321,000
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $363,290 - $430,597	5,038	5,038 $408,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Gilead Sciences, Inc. Transaction History